Nature-Cide promotes industry veteran to VP

By

January 26, 2022

Greg Pettis

Greg Pettis

Med-X appointed Gregory Pettis as vice president of business development to drive an expansion of its global customer base for products in its Nature-Cide division.

Pettis brings 28 years of sales and business management experience to Med-X. He is an industry educator, and founder of Lancaster, Pa.-based Dominion Pest Control. Dominion Pest Control is a certified partner representative for Med-X’s Nature-Cide products.

Over the years, Pettis has worked closely with the Nature-Cide staff to ensure that customers were consistently satisfied with the experience they received from the team.

Matthew Mills, CEO of Med-X, said in a news release Pettis’ relationship with other partners in the pest control industry will help Nature-Cide to enhance its distribution footprint. He added that Pettis provides “a truly unique perspective that few business development professionals can offer.”

“I am truly privileged to join the team at Med-X, and excited to build on the company’s solid roster of existing strategic partnerships,” Pettis said. “As a representative for Nature-Cide, I have long been impressed by its safety and efficacy, which my customers have long appreciated. My chief focus at Med-X will be to uncover new partnerships to enhance sell-through, with the end-goal of higher revenues to the business.”

About Med-X

Med-X is a leading innovator of all-natural green scene solutions addressing the international pest controlhealth and wellness markets. Capitalizing on its diverse family of in-house brands to offer safe alternatives to conventional chemical and pharmaceutical products using all-natural ingredients, Med-X’s comprehensive go-to-market strategy includes an integrated e-commerce, brick-and-mortar distributor and on-site services presence in key national markets.

Category:

About the Author

Ellen Wagner

Ellen Wagner is the digital editor for PMP magazine. She can be reached at ewagner@northcoastmedia.net.

Leave A Comment

Comments are closed.